• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Shiladitya Sengupta

Assistant Professor, Department of Medicine, Harvard Medical School

Assistant Professor, Department of Health Sciences and Technology, Harvard Medical School

Associate Bioengineer, Medicine, Brigham And Women's Hospital

Contact Info

Shiladitya Sengupta
Brigham and Women's Hospital
65 Landsdowne street

Cambridge, MA, 02139
Phone: 617-768-8994


Not Available.

DF/HCC Program Affiliation

Angiogenesis, Invasion and Metastasis
Breast Cancer

DF/HCC Associations

Principal Investigator, Cancer Pharmacology

Lab Website

Laboratory Website

Research Abstract

Our laboratory is interested in understanding the basic relationships at the cellular level that define a pathological state, and in using this knowledge to develop novel strategies or medicines for treating disease.

How does the cellular microenvironment modulate cellular functions or vice versa? Can the complex sugars that constitute the microenvironment play a cohesive role in intracellular regulation at the protein signaling or genetic levels? These are some key questions that we are probing using novel tools to dissect the complex sugars and connecting what we learn with changes we observe in genetic and protein-signaling. We are using this understanding to engineer novel therapeutic approaches for new drug discovery, for hybrid nanotechnology applications for novel therapeutic strategies, and for regenerative medicine using directed stem cell differentiation.

Reference Publications
Basu S, Harfouche R, Soni S, Chimote G, Mashelkar RA, Sengupta S. Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy. Proc Natl Acad Sci U S A. 2009 May 12;106(19):7957-61. Featured on PNAS Highlights, Forbes, MSN News, CBS, The Telegraph, Yahoo News, Harvard Website.

Sengupta S, Sasisekharan R. Exploiting nanotechnology to target cancer. Br J Cancer. 2007 May 7;96(9):1315-9.

Sengupta S*, Eavarone DA*, Capila I, Zhao G, Watson N, Kiziltepe T, Sasisekharan R. Novel cancer therapy through temporal targeting of both tumor cells and neovasculature using a unique nanoscale delivery system. Nature (2005) 436, 568-572.


View All Publications